Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
Guardado en:
Autores principales: | Colin Vercueil, Lauriane Eberst, Catherine Humbrecht, Luc-Matthieu Fornecker |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a56ac43367c4b45b8777131353a62f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The expanding role of bendamustine in chronic lymphocytic leukemia
por: Nair KS, et al.
Publicado: (2015) -
Targeting CD20 in chronic lymphocytic leukemia
por: Nahas MR, et al.
Publicado: (2015) -
Coexistence of primary myelofibrosis and chronic lymphocytic leukemia
por: Burgstaller S, et al.
Publicado: (2014) -
Pharmacology and clinical potential of oblimersen sodium in the treatment of chronic lymphocytic leukemia
por: O'Brien S, et al.
Publicado: (2012) -
Treating the elderly patient with chronic lymphocytic leukemia: current and emerging options
por: Mozaheb Z
Publicado: (2014)